3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
2
Adenocarcinoma
2
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Recurrence
1
Prostate Adenocarcinoma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Malignant Liver Neoplasm
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Eyelid Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
Vincristine
1
Temozolomide
1
Taxes
1
Selenomethionine
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Radiotherapy, Image-Guided
×
90 days
×
Clear all
No trials found.